.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Cipla
Boehringer Ingelheim
Mallinckrodt
McKinsey
Chubb
Harvard Business School
Dow
QuintilesIMS
Daiichi Sankyo

Generated: July 23, 2017

DrugPatentWatch Database Preview

NITROPRESS Drug Profile

« Back to Dashboard

What is the patent landscape for Nitropress, and what generic Nitropress alternatives are available?

Nitropress is a drug marketed by Abbvie, Abbott, and Hospira. and is included in four NDAs.

The generic ingredient in NITROPRESS is sodium nitroprusside. There are one thousand three hundred and ninety-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.

Summary for Tradename: NITROPRESS

Patents:0
Applicants:3
NDAs:4
Suppliers / Packagers: see list1
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NITROPRESS at DailyMed

Pharmacology for Tradename: NITROPRESS

Drug ClassVasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
NITROPRESS
sodium nitroprusside
INJECTABLE;INJECTION018450-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Hospira
NITROPRESS
sodium nitroprusside
INJECTABLE;INJECTION070566-001Jun 9, 1986DISCNNoNo► Subscribe► Subscribe
Abbott
NITROPRESS
sodium nitroprusside
INJECTABLE;INJECTION071555-001Nov 16, 1987DISCNNoNo► Subscribe► Subscribe
Hospira
NITROPRESS
sodium nitroprusside
INJECTABLE;INJECTION071961-001Aug 1, 1988APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Novartis
Deloitte
Colorcon
Moodys
Dow
Boehringer Ingelheim
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot